Intraoperative vs Transvaginal Ultrasound in Rectosigmoid Endometriosis
INTREND
Comparative Study of Transvaginal and Intraoperative Ultrasound in Rectosigmoid Deep Infiltrating Endometriosis
1 other identifier
observational
98
0 countries
N/A
Brief Summary
Deep infiltrating endometriosis (DIE) of the rectum and rectosigmoid colon represents one of the most severe forms of endometriosis and often requires surgical management when symptomatic and unresponsive to medical therapy. Accurate preoperative assessment of lesion size, extent, and depth of bowel infiltration is essential to guide surgical planning and minimize complications. Transvaginal ultrasound (TVUS) is the first-line imaging technique for the diagnosis of pelvic endometriosis and has high diagnostic accuracy for detecting rectosigmoid lesions. However, its ability to precisely assess infiltration depth and guide the choice of surgical technique may be limited by anatomical distortion and technical factors. Intraoperative ultrasound (IO-US) is a real-time imaging modality that can be performed during laparoscopic surgery after adhesiolysis, allowing direct evaluation of bowel lesions. It may improve the assessment of lesion characteristics and support intraoperative decision-making, potentially reducing unnecessary bowel resections. This prospective single-center comparative study aims to evaluate the agreement between preoperative TVUS and intraoperative ultrasound in measuring rectal and rectosigmoid DIE nodules. Secondary objectives include assessing measurement differences, identifying factors associated with discordance, and evaluating the reproducibility of ultrasound measurements. The findings of this study may improve preoperative counseling, optimize surgical planning, and support the integration of intraoperative ultrasound into the management of bowel endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedStudy Start
First participant enrolled
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 7, 2028
April 8, 2026
March 1, 2026
1 year
April 1, 2026
April 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Agreement Between TVUS and IO-US Measurements
Agreement between preoperative transvaginal ultrasound (TVUS) and intraoperative ultrasound (IO-US) in measuring rectal and rectosigmoid deep infiltrating endometriosis nodules, assessed using the intraclass correlation coefficient (ICC).
12 months
Secondary Outcomes (3)
Measurement Difference Between TVUS and IO-US
12 months
Agreement Analysis Between TVUS and IO-US
12 months
Intraobserver and Interobserver Reproducibility
12 months
Eligibility Criteria
Women with suspected deep infiltrating endometriosis of the posterior compartment involving the rectum or rectosigmoid colon who are scheduled for surgical treatment.
You may qualify if:
- Women aged 18 to 55 years
- Clinical and/or imaging suspicion of rectal or rectosigmoid deep infiltrating endometriosis (DIE)
- Indication for laparoscopic or robotic surgery for DIE
- Ability and willingness to provide written informed consent
You may not qualify if:
- Previous bowel resection for deep infiltrating endometriosis
- Active inflammatory bowel disease
- Pregnancy
- Technical inability to perform transvaginal or intraoperative ultrasound
- Refusal or withdrawal of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giorgia Gaia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 8, 2026
Study Start
April 7, 2026
Primary Completion (Estimated)
April 7, 2027
Study Completion (Estimated)
July 7, 2028
Last Updated
April 8, 2026
Record last verified: 2026-03